Elsevier Introduces Article-Based Publishing to Increase Publication Speed

Final and Citable Articles are Published Without Needing to Wait Until a Journal Issue is Complete; Speeding the Publication Process by an Average of 7 Weeks

AMSTERDAM, October 6, 2010 - Elsevier, the world-leading publisher of scientific, technical and
medical information products and solutions, announced today the launch of
Article-Based Publishing — a new publishing model that publishes articles as
final and citable without needing to wait until a journal issue is complete.
With an increasing focus on online publishing, there is a growing need for
innovative publication models geared towards individual articles instead of
the print-based issue model. Article-Based Publishing is the assigning of
final citation data on an article-by-article basis, decoupled from the
compilation of the journal issue itself.

"Article-Based Publishing is major step forward in publishing. Now the
article is published in its final form within just a few weeks after
acceptance, which provides the journal an important competitive advantage,"
said Professor Rene Janssen, Editor of Organic Electronics. "Authors will be
equally pleased to see the results of their research published sooner."

For centuries, academic articles have been published in journals, issue
by issue. While this practice has ensured organized citation information, it
has also created boundaries for the timing of each published article. Now,
Article-Based Publishing makes it possible to publish articles in their final
form, with volume, issue and page numbers, before the entire issue is
finalised. This new way of publishing speeds up the publication of articles
by an average of 7 weeks.

For journals using the Article-Based Publishing model, articles are
published in an "Issue in Progress" on SciVerse ScienceDirect (
www.sciverse.com/). The traditional volume and issue numbering system
will remain as this is the industry standard, and it also provides context to
when the complete journal issue was published. Next to the Issue in Progress,
a diminishing Article in Press list will still exist for accepted manuscripts
and uncorrected proofs only. These articles, although not officially
published, are still valuable for fast access to new research results.

"Article-Based Publishing is a key part of Elsevier's efforts to find new
ways to speed up and enhance the publication process," said Martin Tanke,
Managing Director of S&T Journals for Elsevier. "Along with PeerChoice
(www.elsevier.com/wps/find/authored_newsitem.cws_home/companynews05_01
567) and Article of the Future (
www.elsevier.com/wps/find/authored_newsitem.cws_home/companynews05_012
79), we're continuously addressing our community's requests for publishing
innovation."

Elsevier in 2011 also intends to make it possible to have multiple issues
in progress at the same time for one journal. This will allow simultaneous
publication of special, thematic and regular issues, further reducing article
publication times.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com/) and Cell
(www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/), Reaxys (https://www.reaxys.com/), MD Consult
(www.mdconsult.com/) and Nursing Consult (
www.nursingconsult.com/), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com/) and
MEDai's Pinpoint Review (www.medai.com/), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com/) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com/), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media contact

    Harald Boersma
    Senior Manager, Corporate Relations, Elsevier
    H.Boersma@elsevier.com
    +31-20-485-27-36

Media contact: Harald Boersma, Senior Manager, Corporate Relations, Elsevier, H.Boersma at elsevier.com , +31-20-485-27-36.